The cell adhesion molecule VCAM1 directs microglia towards ApoE-associated amyloid-β (Aβ) plaques, leading to Aβ clearance, according to new research published in Nature Aging. The results of the study highlight this signalling pathway as a potential therapeutic target for Alzheimer disease (AD).
Latest article
Take it from the rats: A junk food diet can cause long-term damage to...
A new USC-led study on rats that feasted on a high-fat, sugary diet raises the possibility that a junk food-filled diet in teens may...
Repurposing non-pharmacological interventions for Alzheimer’s disease through link prediction on biomedical literature
The complete workflow is depicted in Fig. 1. To investigate the association between NPIs and AD, we initially conducted preprocessing and integration of biomedical triples...
Degenerative Dementias and Their Medical Care in the Movies
Compared with other neurologic problems, few films have been dedicated to degenerative dementia. To our knowledge, this is the first systematic review about the...
